The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

Raulet, D. H. Roles of the NKG2D immunoreceptor and its ligands. Nature Rev. Immunol. 3, 781–790 (2003)

Abraham, R. T. Cell cycle checkpoint signalling through the ATM and ATR kinases. Genes Dev. 15, 2177–2196 (2001)

Xing, D. & Orsulic, S. A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumour resistance. Proc. Natl Acad. Sci. USA 102, 6936–6941 (2005)

Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499–506 (2003)

Osborn, A. J., Elledge, S. J. & Zou, L. Checking on the fork: the DNA-replication stress-response pathway. Trends Cell Biol. 12, 509–516 (2002)

Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaccmaz, K. & Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73, 39–85 (2004)

Sarkaria, J. N. et al. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent, caffeine. Cancer Res. 59, 4375–4382 (1999)

Brown, E. J. & Baltimore, D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev. 17, 615–628 (2003)

Nyberg, K. A., Michelson, R. J., Putnam, C. W. & Weinert, T. A. Toward maintaining the genome: DNA damage and replication checkpoints. Annu. Rev. Genet. 36, 617–656 (2002)

Weitzman, M. D., Carson, C. T., Schwartz, R. A. & Lilley, C. E. Interactions of viruses with the cellular DNA repair machinery. DNA Repair (Amst.) 3, 1165–1173 (2004)

Lodoen, M. et al. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197, 1245–1253 (2003)

Bartek, J. & Lukas, J. Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421–429 (2003)

Mills, K. D., Ferguson, D. O. & Alt, F. W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 194, 77–95 (2003)

Sieber, O. M., Heinimann, K. & Tomlinson, I. P. Genomic instability–the engine of tumorigenesis? Nature Rev. Cancer 3, 701–708 (2003)

Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907–913 (2005)

Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870 (2005)

Gonzalez, S., Prives, C. & Cordon-Cardo, C. p73alpha regulation by Chk1 in response to DNA damage. Mol. Cell. Biol. 23, 8161–8171 (2003)

Bignami, M., Casorelli, I. & Karran, P. Mismatch repair and response to DNA-damaging antitumour therapies. Eur. J. Cancer 39, 2142–2149 (2003)

Zhou, B. B. & Bartek, J. Targeting the checkpoint kinases: chemosensitization versus chemoprotection. Nature Rev. Cancer 4, 216–225 (2004)

Jamieson, A. M. et al. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 17, 19–29 (2002)

Brown, E. J. & Baltimore, D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev. 14, 397–402 (2000)

Lander, M. R., Moll, B. & Rowe, W. P. A procedure for culture of cells from mouse tail biopsies: brief communication. J. Natl Cancer Inst. 60, 477–478 (1978)

Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. & Raulet, D. H. Ligands for the murine NKG2D receptor: expression by tumour cells and activation of NK cells and macrophages. Nature Immunol. 1, 119–126 (2000)

Diefenbach, A., Hsia, J. K., Hsiung, M. Y. & Raulet, D. H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumour immunity. Eur. J. Immunol. 33, 381–391 (2003)

Krause, D. R. et al. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Oncogene 22, 5927–5937 (2003)

Zhang, X. et al. Artemis is a phosphorylation target of ATM and ATR and is involved in the G2/M DNA damage checkpoint response. Mol. Cell. Biol. 24, 9207–9220 (2004)

Hernandez-Hoyos, G., Anderson, M. K., Wang, C., Rothenberg, E. V. & Alberola-Ila, J. GATA-3 expression is controlled by TCR signals and regulates CD4/CD8 differentiation. Immunity 19, 83–94 (2003)